The the Court of Justice for the European Union reports a decrease in new IP cases in 2024 despite a 12% increase in overall ...

Experts underestimated Trump's seriousness on tariffs; Indian auto and pharma sectors brace for impact, while steel remains ...

B.C. government B.C. Supreme Court opioid case against pharmaceutical companies can move ahead, appeal court rules in ...

The global extended release drugs market is experiencing significant growth, projected to expand at a robust 11% CAGR from 2022 to 2032. With a valuation of USD 48 billion in 2022, the market is ...

The government alleges that, from 1996 — when the Purdue‑related defendants first introduced and began to improperly market OxyContin in Canada — to the present, the class members paid ...

The Competition and Markets Authority (CMA) took the action against Auden Mckenzie and Actavis UK – now known as Accord-UK – and other companies after an investigation into the price of ...

Two of the most notable examples of this in recent years are Actavis (now owner of Allergan and to take Allergan's name globally) and Gilead. Actavis was a generics giant whose rise mirrors the ...

Michael L. Krychman, MD; Jan L. Shifren, MD, NCMP; James H. Liu, MD; Sheryl L. Kingsberg, PhD; Wulf H. Utian, MB BCh, PhD, DSc(Med), FRCOG, FACOG, FICS ...

B.C.’s Court of Appeal has upheld a lower court decision that the provincial government can sue opioid-distributing companies in the province’s supreme court as a putative class-action suit.

Investing.com – U.S. equities were lower at the close on Wednesday, as losses in the Healthcare, Industrials and Financials ...